Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 51–100 of 137 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04648904	Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer	active not recruiting	Early Phase 1	71	Memorial Sloan Kettering Cancer CenterOTHER	1	May 26, 2026	clinicaltrials
NCT06308913	Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma	active not recruiting	Early Phase 1	10	University of Wisconsin, MadisonOTHER	1	May 26, 2026	clinicaltrials